Health Technology/clinical-trials

Singapore Trial Tests Community Health Coach-Led Digital Program for Metabolic Syndrome — Novel Self-Regulation Approach Under Study

247 Health News Editorial

·

9 Apr 2026

·

4 min read

·clinical-trials

Singapore researchers are testing LIGHTER-MetS, a community-based health coaching program combined with digital technology for metabolic syndrome management. The 316-participant study focuses on improving dietary self-regulation and reducing cardiovascular risk through integrated lifestyle intervention.

Originally reported by ClinicalTrials.gov

References

  1. 1.National University Health System Singapore. (2024). Effectiveness and Implementation of a Community-based Health Coach-led Artificial Intelligence (AI)-Powered Digital Self-Regulation Program for Individuals With Metabolic Syndrome. ClinicalTrials.gov. NCT07410325. https://clinicaltrials.gov/study/NCT07410325
  2. 2.Saklayen, M. G. (2018). The Global Epidemic of the Metabolic Syndrome. Current Hypertension Reports, 20(2), 12. https://doi.org/10.1007/s11906-018-0812-z
  3. 3.Alberti, K. G., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., ... & Smith, S. C. (2009). Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention. Circulation, 120(16), 1640-1645. https://doi.org/10.1161/CIRCULATIONAHA.109.192644
  4. 4.Whitehead, L., & Seaton, P. (2016). The effectiveness of self-management mobile phone and tablet apps in long-term condition management: a systematic review. Journal of Medical Internet Research, 18(5), e4883. https://doi.org/10.2196/jmir.4883
  5. 5.Kliemann, N., Beeken, R. J., Wardle, J., & Johnson, F. (2016). Development and validation of the self-regulation of eating behaviour questionnaire for adults. International Journal of Behavioral Nutrition and Physical Activity, 13(1), 87. https://doi.org/10.1186/s12966-016-0414-6
Share:XLinkedIn
2

247 Health News Editorial

247 Health News is a medical intelligence platform delivering evidence-based research appraisals, clinical trial monitoring, and health technology news for healthcare professionals.

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service